NDC properties for "adalimumab-fkjp 20 MG per 0.4 ML Prefilled Syringe" (RxCUI 2640412)
About this data
The tables show NDC propoerties for adalimumab-fkjp 20 MG per 0.4 ML Prefilled Syringe with the RxCUI 2640412
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-fkjp 20 MG per 0.4 ML Prefilled Syringe (RxCUI 2640412)
| BLA | BLA761154 |
|---|---|
| MMSL_CODE | BD39565 |
| RxCUI | 2640412 |
| SPL_SET_ID | 5cde907d-6747-0e62-db25-1718ee717fe7 |
| SPL_SET_ID | e94548f8-6a95-4159-9db8-6e734febbea0 |
| VUID | 4042356 |
| Prescribable Synonym | adalimumab-fkjp 20 MG in 0.4 ML Prefilled Syringe |
| RXNAV_STR | 0.4 ML adalimumab-fkjp 50 MG/ML Prefilled Syringe |
| RxNorm Name | 0.4 ML adalimumab-fkjp 50 MG/ML Prefilled Syringe |
| RxNorm Synonym | adalimumab-fkjp 20 MG per 0.4 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2640412) |
NDC Properties
NDC Item 49502041702
| NDC 9 | 49502-417 |
|---|---|
| NDC 10 | 49502-417-02 |
| NDC Item | 49502041702 |
| Packaging | 2 TRAY in 1 KIT (49502-417-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (49502-484-06) * 2 PACKET in 1 KIT (49502-485-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-10-31 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-417 |
NDC Item 49502041706
| NDC 9 | 49502-417 |
|---|---|
| NDC 10 | 49502-417-06 |
| NDC Item | 49502041706 |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-10-31 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-417 |
NDC Item 83257002042
| NDC 9 | 83257-020 |
|---|---|
| NDC 10 | 83257-020-42 |
| NDC Item | 83257002042 |
| Packaging | 2 TRAY in 1 KIT (83257-020-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 788036 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-020 |
NDC Item 49502041702
| NDC 9 | 49502-417 |
|---|---|
| NDC 10 | 49502-417-02 |
| NDC Item | 49502041702 |
| Packaging | 2 TRAY in 1 KIT (49502-417-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (49502-484-06) * 2 PACKET in 1 KIT (49502-485-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-10-31 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-417 |
NDC Item 49502041706
| NDC 9 | 49502-417 |
|---|---|
| NDC 10 | 49502-417-06 |
| NDC Item | 49502041706 |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-10-31 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-417 |
NDC Item 83257002042
| NDC 9 | 83257-020 |
|---|---|
| NDC 10 | 83257-020-42 |
| NDC Item | 83257002042 |
| Packaging | 2 TRAY in 1 KIT (83257-020-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 788036 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-020 |
NDC Item 49502041702
| NDC 9 | 49502-417 |
|---|---|
| NDC 10 | 49502-417-02 |
| NDC Item | 49502041702 |
| Packaging | 2 TRAY in 1 KIT (49502-417-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (49502-484-06) * 2 PACKET in 1 KIT (49502-485-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-10-31 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-417 |
NDC Item 49502041706
| NDC 9 | 49502-417 |
|---|---|
| NDC 10 | 49502-417-06 |
| NDC Item | 49502041706 |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-10-31 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-417 |
NDC Item 83257002042
| NDC 9 | 83257-020 |
|---|---|
| NDC 10 | 83257-020-42 |
| NDC Item | 83257002042 |
| Packaging | 2 TRAY in 1 KIT (83257-020-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 788036 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-020 |